These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 35142822)
1. Risk Stratification of Prostatic Adenocarcinoma Metastatic to the Lymph Nodes. Bidot S; Monsrud A; Kline M; Speak A; Martini D; Bilen MA; Switchenko JM; Zhang Y; Gerges AG; Farhat GN; Dent EA; Master VA; Tinsley ML; Harik LR Arch Pathol Lab Med; 2022 Nov; 146(11):1345-1352. PubMed ID: 35142822 [TBL] [Abstract][Full Text] [Related]
2. The stratification of positive lymph nodes into pN1 and pN2 for upper urinary tract carcinoma is not prognostically significant. Wu DJ; Wong MN; Lee CT; Zynger DL Hum Pathol; 2023 Jul; 137():48-55. PubMed ID: 37088434 [TBL] [Abstract][Full Text] [Related]
3. Outcomes after radical prostatectomy for patients with clinical stages T1-T2 prostate cancer with pathologically positive lymph nodes in the prostate-specific antigen era. Dorin RP; Lieskovsky G; Fairey AS; Cai J; Daneshmand S Urol Oncol; 2013 Nov; 31(8):1441-7. PubMed ID: 22516714 [TBL] [Abstract][Full Text] [Related]
4. [Effect of number of metastatic lymph nodes and metastatic lymph node ratio on the prognosis in patients with adenocarcinoma of the esophagogastric junction after curative resection]. Zhang H; Chen C; Yue J; Ma M; Ma Z; Yu Z Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):141-6. PubMed ID: 24796465 [TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer. Wu MH; Shen WT; Gosnell J; Duh QY Head Neck; 2015 Sep; 37(9):1336-43. PubMed ID: 24821456 [TBL] [Abstract][Full Text] [Related]
6. Long-term oncological outcomes in patients with limited nodal disease undergoing radical prostatectomy and pelvic lymph node dissection without adjuvant treatment. Mandel P; Rosenbaum C; Pompe RS; Steuber T; Salomon G; Chun FK; Graefen M; Huland H; Tilki D World J Urol; 2017 Dec; 35(12):1833-1839. PubMed ID: 28828530 [TBL] [Abstract][Full Text] [Related]
7. Association of Pathologic Nodal Staging Quality With Survival Among Patients With Non-Small Cell Lung Cancer After Resection With Curative Intent. Smeltzer MP; Faris NR; Ray MA; Osarogiagbon RU JAMA Oncol; 2018 Jan; 4(1):80-87. PubMed ID: 28973110 [TBL] [Abstract][Full Text] [Related]
8. Pathologic nodal staging scores in patients treated with radical prostatectomy: a postoperative decision tool. Kluth LA; Abdollah F; Xylinas E; Rieken M; Fajkovic H; Sun M; Karakiewicz PI; Seitz C; Schramek P; Herman MP; Becker A; Loidl W; Pummer K; Nonis A; Lee RK; Lotan Y; Scherr DS; Seiler D; Chun FK; Graefen M; Tewari A; Gönen M; Montorsi F; Shariat SF; Briganti A Eur Urol; 2014 Sep; 66(3):439-46. PubMed ID: 23850255 [TBL] [Abstract][Full Text] [Related]
10. Effect of the number of positive lymph nodes and lymph node ratio on prognosis of patients after resection of pancreatic adenocarcinoma. Liu ZQ; Xiao ZW; Luo GP; Liu L; Liu C; Xu J; Long J; Ni QX; Yu XJ Hepatobiliary Pancreat Dis Int; 2014 Dec; 13(6):634-41. PubMed ID: 25475867 [TBL] [Abstract][Full Text] [Related]
11. Assessment of lymph node status in gallbladder cancer: location, number, or ratio of positive nodes. Shirai Y; Sakata J; Wakai T; Ohashi T; Ajioka Y; Hatakeyama K World J Surg Oncol; 2012 May; 10():87. PubMed ID: 22594526 [TBL] [Abstract][Full Text] [Related]
12. Predicting biochemical recurrence-free survival for patients with positive pelvic lymph nodes at radical prostatectomy. von Bodman C; Godoy G; Chade DC; Cronin A; Tafe LJ; Fine SW; Laudone V; Scardino PT; Eastham JA J Urol; 2010 Jul; 184(1):143-8. PubMed ID: 20478587 [TBL] [Abstract][Full Text] [Related]
13. Robotic extended pelvic lymphadenectomy for intermediate- and high-risk prostate cancer. Yuh BE; Ruel NH; Mejia R; Wilson CM; Wilson TG Eur Urol; 2012 May; 61(5):1004-10. PubMed ID: 22366188 [TBL] [Abstract][Full Text] [Related]
14. Prognosis for gastric carcinomas with an insufficient number of examined negative lymph nodes. Martinez-Ramos D; Calero A; Escrig-Sos J; Mingol F; Daroca-Jose JM; Sauri M; Arroyo A; Salvador-Sanchis JL; de Juan M; Calpena R; Lacueva FJ Eur J Surg Oncol; 2014 Mar; 40(3):358-65. PubMed ID: 24075824 [TBL] [Abstract][Full Text] [Related]
15. Number of metastatic lymph nodes as determinant of outcome after salvage radical prostatectomy for radiation-recurrent prostate cancer. Gugliemetti G; Sukhu R; Conca Baenas MA; Meeks J; Sjoberg DD; Eastham JA; Scardino PT; Touijer K Actas Urol Esp; 2016 Sep; 40(7):434-9. PubMed ID: 27184342 [TBL] [Abstract][Full Text] [Related]
17. Head-to-head comparison of lymph node density and number of positive lymph nodes in stratifying the outcome of patients with lymph node-positive prostate cancer submitted to radical prostatectomy and extended lymph node dissection. Passoni NM; Abdollah F; Suardi N; Gallina A; Bianchi M; Tutolo M; Fossati N; Gandaglia G; Salonia A; Freschi M; Rigatti P; Montorsi F; Briganti A Urol Oncol; 2014 Jan; 32(1):29.e21-8. PubMed ID: 23490908 [TBL] [Abstract][Full Text] [Related]